Drug intelligence / Profile preview

hecogenin

Development stage
Preclinical
Modality
Small Molecules
Administration
Intraperitoneal, Oral, Topical
01

Overview

Hecogenin is a naturally occurring steroidal sapogenin primarily extracted from plants of the *Agave* genus, such as *Agave sisalana*. It is a significant industrial precursor used in the semi-synthesis of various steroid hormones, including corticosteroids. Beyond its role as a chemical intermediate, hecogenin has been investigated for its bioactive properties, particularly in the context of inflammatory and proliferative diseases. Research indicates that hecogenin can induce apoptosis in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS) by activating the p38 mitogen-activated protein kinase (MAPK) signaling pathway. This pro-apoptotic activity is associated with the upregulation of cyclooxygenase-2 (COX-2) expression and an increase in endogenous prostaglandin E2 (PGE2) production, highlighting its potential as a therapeutic candidate for managing synovial hyperplasia in RA.

Other names
Hecogenine(3beta,5alpha,25R)-3-hydroxyspirostan-12-one
02

Targets

BACE1 (Beta-site APP-cleaving enzyme 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CASP3 (Caspase-3)EthR;EthR2 (EthR/EthR2)CASP9 (Caspase-9)RK (Ribokinase)CASP8 (Caspase-8)

Beyond the preview

Go deeper on hecogenin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hecogenin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call